Filing Flows › bioAffinity Technologies (BIAF) › Health Care, Patient Service revenue
bioAffinity Technologies (BIAF) Health Care, Patient Service revenue by quarter
bioAffinity Technologies' Health Care, Patient Service revenue was $863K in Q3 2026 (third quarter 2026), -31% from Q2 2026. Over the last 6 quarters it ranged from $863K (Q3 2026) to $1.6M (Q1 2025).
| Quarter | Health Care, Patient Service revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $863K | -31% | -26% |
| Q2 2026 | $1.2M | +15% | — |
| Q1 2026 | $1.1M | -16% | -31% |
| Q4 2025 | $1.3M | +10% | — |
| Q3 2025 | $1.2M | -25% | — |
| Q1 2025 | $1.6M | — | — |
Q3 2026 at a glance
bioAffinity Technologies, Q3 2026: revenue $1.1M (-26% year over year), operating margin -328.0%, net loss $5.3M, operating cash flow −$3.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is bioAffinity Technologies' Health Care, Patient Service revenue?
bioAffinity Technologies' Health Care, Patient Service revenue was $863K in Q3 2026 (third quarter 2026), -31% from Q2 2026.
How has bioAffinity Technologies' Health Care, Patient Service revenue changed?
Over the last 6 quarters it ranged from $863K (Q3 2026) to $1.6M (Q1 2025).
Q3 2026 results → · How bioAffinity Technologies makes money →